Literature DB >> 24761853

Epidemiological and clinicopathological characteristics of lung cancer in a teaching hospital in Iran.

Fatemeh Hajmanoochehri1, Navid Mohammadi, Mohammad Ali Zohal, Abolfazl Sodagar, Mehdi Ebtehaj.   

Abstract

BACKGROUND: Lung cancer is one of the most commonly diagnosed cancers and the most frequent cause of cancer-related death worldwide. In Iran, it ranks second and third as the cancer-causing death in men and women, respectively. We carried out this study to find out the demographic, clinical, and histological characteristics and risk factors of lung cancer in a referral tertiary center in Iran.
MATERIALS AND METHODS: A retrospective study was conducted on cases of primary lung cancer based on the results of registered cancer reports of cytological and pathological specimens between March 2001 and March 2012. Demographic variables, clinical manifestations, histology and location of tumors were determined based on the data found in the medical records of each patient. Definite or probable etiologic factors were identified. Data analysis was performed with SPSS version 16 and a p-value ≤ 0.05 was considered as significant.
RESULTS: A total of 203 patients, with a mean age of 65.7 years (SD=11.2), with primary lung cancer were identified, 81.3% being men. Of the total, 110 cases (54.2%) were living in urban areas. In 53.2% of cases, the site of tumor was on the right side and in 72.9% of cases the lesion was centrally located. The histological types of lung cancer were squamous cell carcinoma (SCC) in 107 cases (52.7%), adenocarcinoma (AC) in 30 cases (14.8%), and small cell carcinoma (SC) in 27 cases (13.3%). Significant correlations between the gender and residence, smoking, and the histological type and location (central or peripheral) of tumor were found. The percentage of smokers was 75.2% in men and 15.8% in women.
CONCLUSIONS: Smoking was the most important risk factor and squamous cell carcinoma the most common histological type of lung cancer in our study. Male sex and being a smoker was associated with histological types of SCC while being nonsmoker had relationship with adenocarcinoma.

Entities:  

Mesh:

Year:  2014        PMID: 24761853     DOI: 10.7314/apjcp.2014.15.6.2495

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Trends in the incidence rate of lung cancer by histological type and gender in Sichuan, China, 1995-2015: A single-center retrospective study.

Authors:  Xiaoxuan Zhang; Li Wu; Yong Xu; Benxia Zhang; Xueqian Wu; Yongsheng Wang; Zongguo Pang
Journal:  Thorac Cancer       Date:  2018-03-05       Impact factor: 3.500

Review 2.  A review of incidence and mortality of colorectal, lung, liver, thyroid, and bladder cancers in Iran and compared to other countries.

Authors:  Bagher Farhood; Behzad Raei; Reza Malekzadeh; Maryam Shirvani; Masoud Najafi; Tohid Mortezazadeh
Journal:  Contemp Oncol (Pozn)       Date:  2019-04-05

3.  Epidemiology of lung cancer in northeast of Iran: A 25-year study of 939 patients.

Authors:  Mahta Salehi; Maryam Salehi; Soodabeh Shahidsales; Golboo Goshayeshi; Maryam Emadzadeh; Mahdi Seilanian Toosi; Seyed-Amir Aledavood; Seyede Samaneh Hoseini; Pardis Shojaei
Journal:  Med J Islam Repub Iran       Date:  2020-03-07

4.  Clinical Characteristics and Molecular Profiles of Lung Cancer in Ethiopia.

Authors:  Tewodros H Gebremariam; Deborah A Haisch; Helen Fernandes; Dawit K Huluka; Amsalu B Binegdie; Mathewos A Woldegeorgis; Wondwosen Ergetie; Aschalew Worku; Lillian M Zerihun; Matthew Cohen; Pierre P Massion; Charles B Sherman; Anjali Saqi; Neil W Schluger
Journal:  JTO Clin Res Rep       Date:  2021-05-31

Review 5.  Epidemiological Study of Lung Cancer in Iran: A Systematic Review.

Authors:  Hamid Salehiniya; Mohammadkarim Bahadori; Ghader Ghanizadeh; Mehdi Raei
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

6.  Epidermal Growth Factor Receptor Mutations in Lung Adenocarcinomas: A Single Center Study from Iran

Authors:  Ali Basi; Flora Khaledi; Mohammad Hadi Karbalaie Niya; Hamid Rezvani; Nasser Rakhshani
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.